Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate

IF 3.5 3区 化学 Q2 CHEMISTRY, APPLIED Organic Process Research & Development Pub Date : 2025-04-03 DOI:10.1021/acs.oprd.4c00504
Kai-Jiong Xiao, Yonggang Chen, Yingju Xu, Gao Shang, Lushi Tan, Fangzhou Xie, Chengqian Xiao, Yongpeng Yuan, Baoqiang Wan, Guiquan Liu, Jingjun Yin
{"title":"Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate","authors":"Kai-Jiong Xiao, Yonggang Chen, Yingju Xu, Gao Shang, Lushi Tan, Fangzhou Xie, Chengqian Xiao, Yongpeng Yuan, Baoqiang Wan, Guiquan Liu, Jingjun Yin","doi":"10.1021/acs.oprd.4c00504","DOIUrl":null,"url":null,"abstract":"Here we report the development of a large-scale manufacturing process for the synthesis of the Northern Fragment of enlicitide decanoate (MK-0616), an orally bioavailable inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9). The key topics covered are (1) process development for the selective tryptophan allylation; (2) development of the one-pot process for two consecutive peptide coupling reactions; (3) process development for the one-pot cleavage of two <i>N</i>-<i>tert</i>-butyloxycarbonyl (<i>N</i>-Boc) groups and a <i>tert</i>-butyl ester; and (4) process development of the magnesium chloride (MgCl<sub>2</sub>)-mediated selective macrolactamization. This optimized process was demonstrated to produce the key fragment at &gt;150 kg scale per batch in the synthesis of enlicitide.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"41 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1021/acs.oprd.4c00504","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

Here we report the development of a large-scale manufacturing process for the synthesis of the Northern Fragment of enlicitide decanoate (MK-0616), an orally bioavailable inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9). The key topics covered are (1) process development for the selective tryptophan allylation; (2) development of the one-pot process for two consecutive peptide coupling reactions; (3) process development for the one-pot cleavage of two N-tert-butyloxycarbonyl (N-Boc) groups and a tert-butyl ester; and (4) process development of the magnesium chloride (MgCl2)-mediated selective macrolactamization. This optimized process was demonstrated to produce the key fragment at >150 kg scale per batch in the synthesis of enlicitide.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PCSK9抑制剂烯酸酯关键片段的研究进展
在这里,我们报道了大规模生产工艺的发展,以合成enlicicitide decanoate (MK-0616)的北部片段,这是一种口服生物有效的蛋白转化酶枯草杆菌素/克辛9型(PCSK9)抑制剂。主要内容包括:(1)选择性色氨酸烯丙化的工艺发展;(2)开发了两个连续肽偶联反应的一锅工艺;(3)一锅裂解两个n -叔丁基氧羰基(N-Boc)基团和一个叔丁基酯的工艺开发;(4)氯化镁(MgCl2)介导的选择性大内酰胺化的工艺发展。结果表明,优化后的工艺能以每批150 kg的规模生产烯醛酸苷合成中的关键片段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.90
自引率
14.70%
发文量
251
审稿时长
2 months
期刊介绍: The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.
期刊最新文献
Purge Factor Analysis and Proposal for Non-conjugatable Impurity Clearance in Post-conjugation Purification of ADCs Process Optimization and Reaction Kinetic Study of Propylene Glycol Butyl Ether Synthesis from Propylene Oxide in a Microreactor Applications of Infrared Spectroscopy in Monitoring Solvent Distillation during Early-Phase Pharmaceutical Process Development─Lean Chemometrics to Address Temperature and Matrix Effects Perspectives on Sustainability in the Pharmaceutical Industry Process Development for a TLR-7 Immunostimulatory Drug-Linker: Salt Screening and Precipitation for Drug-Linker Intermediates
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1